Paragon 28 Net Profit Margin 2020-2022 | FNA
Paragon 28 net profit margin from 2020 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Paragon 28 Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2022-03-31 | $0.11B | $-0.02B | -14.55% |
| 2021-09-30 | $0.10B | $-0.00B | -4.04% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.281B | $0.147B |
| Paragon 28 Inc. is a medical device company exclusively focused on the foot and ankle orthopedic market. Paragon 28 Inc. is based in ENGLEWOOD, Colo. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $214.627B | 21.80 |
| Edwards Lifesciences (EW) | United States | $60.552B | 42.53 |
| Alcon (ALC) | Switzerland | $35.080B | 30.59 |
| STERIS (STE) | Ireland | $21.113B | 26.67 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.716B | 13.22 |
| Teleflex (TFX) | United States | $11.964B | 19.12 |
| Globus Medical (GMED) | United States | $5.873B | 29.30 |
| Penumbra (PEN) | United States | $4.736B | 299.29 |
| Integer Holdings (ITGR) | United States | $2.383B | 18.51 |
| Glaukos (GKOS) | United States | $2.256B | 0.00 |
| Nevro (NVRO) | United States | $1.608B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.313B | 23.51 |
| Artivion (AORT) | United States | $0.772B | 83.52 |
